Opyl Limited (ASX:OPL)

11.0¢

right-arrow Created with Sketch. -0.01 (-8.33%)
MCAP $5.982M
Last trade 15.29pm 26/11/2021 20mins delayed

Latest Announcements

18/11/2021OPLOpyl Limited
18/11/2021 Price SensitivePSOPLOpyl Limited
18/11/2021OPLOpyl Limited
12/11/2021OPLOpyl Limited
29/10/2021 Price SensitivePSOPLOpyl Limited
19/10/2021OPLOpyl Limited
17/09/2021OPLOpyl Limited

Company Overview

Opyl Limited s a new generation Australian company. The Company provides biopharma and health organizations access to emerging artificial intelligence (AI)-assisted technologies and guidance to understand and improve healthcare design, development and delivery. The Company is focused on executing the change in direction into digital health, rebuilding the research and development pipeline to deliver solutions for the global health and life sciences sector. The Company has built a Opin, which is clinical trial recruitment platform that leverages social media, search engine optimization technologies and artificial intelligence science, matching patients directly to clinical trials. The Company is also developing Clinical trial prediction and protocol design tool. The Company subsidiaries include ShareRoot Inc, ShareRoot (Australian Ops) Pty Ltd, Opyl Services and Ludomade, Inc.

OPL in the news

Medical tech support company Opyl (OPL) has completed an off-market share buy-back…
Medical tech support company Opyl (OPL) has received commitments for a share…
Medical tech support company Opyl (OPL) soared today after announcing it has…

Search Previous Announcements